drugset / Trial / NCT00860223

Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin

NCT00860223

Phase 1 Completed 27 enrolled Puma Biotechnology, Inc.
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the potential effect of multiple doses of neratinib on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of a single dose of digoxin.

Timeline

Start
2009-04
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified Oral
Subject Neratinib Small molecule

Indications

No indication recorded.